InflaRx Statistics
Total Valuation
InflaRx has a market cap or net worth of $81.26 million. The enterprise value is -$14.32 million.
| Market Cap | 81.26M |
| Enterprise Value | -14.32M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, before market open.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
InflaRx has 58.88 million shares outstanding.
| Shares Outstanding | 58.88M |
| Owned by Insiders (%) | 7.34% |
| Owned by Institutions (%) | 29.18% |
| Float | 48.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,150.80 |
| Forward PS | 17.69 |
| PB Ratio | 0.74 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.50, with a Debt / Equity ratio of 0.01.
| Current Ratio | 6.50 |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,196.58 |
Financial Efficiency
Return on equity (ROE) is -40.30% and return on invested capital (ROIC) is -43.31%.
| Return on Equity (ROE) | -40.30% |
| Return on Assets (ROA) | -36.40% |
| Return on Capital (ROIC) | -43.31% |
| Revenue Per Employee | $1,131 |
| Profits Per Employee | -$764,651 |
| Employee Count | 62 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -71.22% in the last 52 weeks. The beta is 1.25, so InflaRx's price volatility has been higher than the market average.
| Beta (1Y) | 1.25 |
| 52-Week Price Change | -71.22% |
| 50-Day Moving Average | 1.55 |
| 200-Day Moving Average | 2.29 |
| Relative Strength Index (RSI) | 41.36 |
| Average Volume (30 Days) | 230,612 |
Short Selling Information
| Short Interest | 389,078 |
| Short Previous Month | 316,707 |
| Short % of Shares Out | 0.71% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.77 |
Income Statement
In the last 12 months, InflaRx had revenue of $70,099 and -$47.41 million in losses. Loss per share was -$0.83.
| Revenue | 70,099 |
| Gross Profit | -499,899 |
| Operating Income | -47.85M |
| Pretax Income | -45.46M |
| Net Income | -47.41M |
| EBITDA | -44.82M |
| EBIT | -45.42M |
| Loss Per Share | -$0.83 |
Balance Sheet
The company has $96.18 million in cash and $1.19 million in debt, giving a net cash position of $94.99 million or $1.61 per share.
| Cash & Cash Equivalents | 96.18M |
| Total Debt | 1.19M |
| Net Cash | 94.99M |
| Net Cash Per Share | $1.61 |
| Equity / Book Value | 109.30M |
| Book Value Per Share | 1.86 |
| Working Capital | 98.69M |
Cash Flow
In the last 12 months, operating cash flow was -$40.29 million and capital expenditures -$86,411, giving a free cash flow of -$40.38 million.
| Operating Cash Flow | -40.29M |
| Capital Expenditures | -86,411 |
| Free Cash Flow | -40.38M |
| FCF Per Share | -$0.74 |
Margins
Gross margin is -713.13%, with operating and profit margins of -68,259.38% and -67,630.59%.
| Gross Margin | -713.13% |
| Operating Margin | -68,259.38% |
| Pretax Margin | -64,853.77% |
| Profit Margin | -67,630.59% |
| EBITDA Margin | -63,936.60% |
| EBIT Margin | -64,799.61% |
| FCF Margin | -57,598.20% |
Dividends & Yields
InflaRx does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.28% |
| Shareholder Yield | -24.28% |
| Earnings Yield | -58.77% |
| FCF Yield | -50.05% |
Analyst Forecast
The average price target for InflaRx is $13.50, which is 871.22% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.50 |
| Price Target Difference | 871.22% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 433.85% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
InflaRx has an Altman Z-Score of -1 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1 |
| Piotroski F-Score | 2 |